[The time of intramammary recurrence after breast-preserving therapy is decisive for patient prognosis].
Fietkau
R
R
D001943:Breast Neoplasms / Q000401:mortality* / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D009364:Neoplasm Recurrence, Local / Q000401:mortality*; D011184:Postoperative Period; D011379:Prognosis; D012189:Retrospective Studies; D013997:Time Factors